Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs CVE✓SelectedUSD · CVEMRNA vs CVE performance historyLatest closeAs of-4.84%11/18
Stock and ETF performance explorer

MRNA vs CVE

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+689.7%
CVE return
+55.1%
Excess return
+634.6%
Maximum drawdown
-34.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioCVEExcessAlpha
1D-4.8%-3.6%-1.2%-5.4%
7D-20.9%-4.2%-16.7%-21.4%
30D-13.3%-18.1%+4.8%-15.9%
3M+212.6%-15.9%+228.4%+206.1%
6M+309.0%-12.9%+321.9%+316.6%
YTD+567.3%+63.6%+503.7%+407.4%
1Y+689.7%+49.5%+640.2%+522.4%
All+689.7%+55.1%+634.6%+522.4%

Cumulative growth

Daily Returns

Daily percentage return beside CVE.

Daily Out/Under-Performance

Portfolio return minus CVE return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CVE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded CVE wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling